1. Home
  2. KRMD vs VYGR Comparison

KRMD vs VYGR Comparison

Compare KRMD & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$3.99

Market Cap

186.5M

Sector

Health Care

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.35

Market Cap

201.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
VYGR
Founded
1980
2013
Country
United States
United States
Employees
N/A
141
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.5M
201.2M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
KRMD
VYGR
Price
$3.99
$3.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$6.50
$16.50
AVG Volume (30 Days)
116.3K
555.6K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
N/A
N/A
Revenue
$41,127,366.00
$10,135,000.00
Revenue This Year
$20.32
$34.04
Revenue Next Year
$17.37
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
22.23
N/A
52 Week Low
$2.91
$2.83
52 Week High
$6.61
$5.55

Technical Indicators

Market Signals
Indicator
KRMD
VYGR
Relative Strength Index (RSI) 45.86 34.70
Support Level $3.82 $3.30
Resistance Level $4.33 $4.29
Average True Range (ATR) 0.15 0.20
MACD 0.00 -0.04
Stochastic Oscillator 31.40 5.52

Price Performance

Historical Comparison
KRMD
VYGR

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: